180
Views
20
CrossRef citations to date
0
Altmetric
Original Article

A pH-sensitive nanocomposite microsphere based on chitosan and montmorillonite with in vitro reduction of the burst release effect

, &
Pages 1106-1114 | Received 06 Dec 2009, Accepted 03 Feb 2010, Published online: 05 Nov 2010

References

  • Muzzarelli R, Baldassarre V, Conti F, Ferrara P, Biagini G, Gazzanelli G, . (1988). Biological activity of chitosan ultrastructural study. Biomaterials, 9(3):247–52.
  • Cao J, Sun J, Wang X, Li X, Deng Y. (2009). N-Trimethyl chitosan-coated multivesicular liposomes for oxymatrine oral delivery. Drug Dev Ind Pharm, 35(11):1339–47.
  • Depan D, Kumar AP, Singh RP. (2009). Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite. Acta Biomater, 5:93–100.
  • Lee MK, Chun SK, Choi WJ, Kim JK, Choi SH, Kim A, . (2005). The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials, 26(14): 2147–56.
  • Jain AK, Chalasani KB, Khar RK, Ahmed FJ, Diwan PV. (2007). Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery. J Drug Target, 15(6): 417–27.
  • Malaekeh-Nikouei B, Tabassi SAS, Jaafari MR. (2008). Preparation, characterization, and mucoadhesive properties of chitosan-coated microspheres encapsulated with cyclosporine A. Drug Dev Ind Pharm, 34(5):492–8.
  • Zhou XF, Zhang XH, Yu XH, Kong W, Shen JC. (2008). The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine. Biomaterials, 29(1):111–7.
  • Ubaidulla U, Khar RK, Ahmed FJ, Panda AK. (2007). Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery. J Pharm Pharmacol, 59(10):1345–51.
  • Akbuga J, Bergisadi N. (1996). 5-fluorouracil-loaded chitosan microspheres: Preparation and release characteristics. J Microencapsul, 13(2):161–68.
  • Kawaguchi H. (2000). Functional polymer microspheres. Prog Polym Sci, 25(8):1171–210.
  • Kumbar SG, Aminabhavi TM. (2003). Synthesis and Characterization of modified chitosan microspheres: Effect of the grafting ratio on the controlled release of nifedipine through microspheres. J Appl Polym Sci, 89:2940–9.
  • Quan JS, Jiang HL, Kim EM, Jeong HJ, Choi YJ, Guo DD, . (2008). pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres. Int J Pharm, 359(1–2):205–10.
  • Paul DR, Robeson LM. (2008). Polymer nanotechnology: Nanocomposites. Polymer, 49(15):3187–204.
  • Wang XY, Du YM, Yang JH, Tang YF, Luo JW. (2008). Preparation, characterization, and antimicrobial activity of quaternized chitosan/organic montmorillonite nanocomposites. J Biomed Mater Res A, 84A(2):384–90.
  • Aguzzi C, Cerezo P, Viseras C, Caramella C. (2007). Use of clays as drug delivery systems: Possibilities and limitations. Appl Clay Sci, 36(1–3):22–36.
  • Feje’r I, Kate M. (2001). Release of cationic drugs from loaded clay minerals. Colloid Polym Sci, 279:1177–82.
  • Park JK, Bin Choy Y, Oh JM, Kim JY, Hwang SJ, Choy JH. (2008). Controlled release of donepezil intercalated in smectite clays. Int J Pharm, 359(1–2):198–204.
  • Zheng JP, Luan L, Wang HY, Xi LF, Yao KD. (2007). Study on ibuprofen/montmorillonite intercalation composites as drug release system. Appl Clay Sci, 36:297–301.
  • Nunes CD, Vaz PD, Fernandes AC, Ferreira P, Romao CC, Calhorda MJ. (2007). Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur J Pharm Biopharm, 66(3):357–65.
  • Peng XH, Zhang L. (2005). Surface fabrication of hollow microspheres from N-methylated chitosan cross-linked with glutaraldehyde. Langmuir, 21(3):1091–5.
  • Lin FH, Lee YH, Jian CH, Wong JM, Shieh MJ, Wang, CY. (2002). A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials, 23(9):1981–7.
  • Illum L. (1998). Chitosan and its use as a pharmaceutical excipient. Pharm Res, 15(9):1326–31.
  • Kumbar SG, Kulkarni AR, Aminabhavi TM. (2002). Crosslinked chitosan microspheres for encapsulation of diclofenac sodium: effect of crosslinking agent. J Microencapsul, 19(2):173–80.
  • Günister E, Pestreli D, ünlu CH, Atici O, Güngör N. (2007). Synthesis and characterization of chitosan-MMT biocomposite systems. Carbohydr Polym, 67:358–65.
  • Cui Y, Zhang Y, Tang X. (2008). In vitro and in vivo evaluation of ofloxacin sustained release pellets. Int J Pharm, 360(1–2):47–52.
  • Gibaldi M, Feldman S. (1967). Establishment of sink conditions in dissolution rate determinations-theoretical considerations and application to nondisintegrating dosage forms. J Pharm Sci, 56(10):1238–42.
  • Wagner JG. (1969). Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci, 58(10):1253–7.
  • Higuchi T. (1963). Mechanism of Sustained-action medication—Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52(12):1145–9.
  • Reza MS, Quadir MA, Haider SS. (2003). Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J Pharm Pharmaceut Sci, 6(2):282–91.
  • Agnihotri SA, Aminabhavi TM. (2004). Controlled release of clozapine through chitosan microparticles prepared by a novel method. J Control Release, 96(2):245–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.